Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Otis W. Brawley"'
Autor:
Otis W. Brawley, Jeromie Ballreich, Lin Wang, Hwanhee Hong, Channing J. Paller, G. Caleb Alexander
Publikováno v:
Value Health
Objectives To assess the cost-effectiveness of systemic treatments for metastatic castration-sensitive prostate cancer from the US healthcare sector perspective with a lifetime horizon. Methods We built a partitioned survival model based on a network
Autor:
Jennie H. Best, Otis W. Brawley, Rachel Baden, James Loveless, Karen S. Miller, Amanda M. Kong, Emma Kaplan-Lewis, Shalini V. Mohan, Krutika Jariwala-Parikh, James L. Zazzali
Publikováno v:
Journal of Medical Virology
This study describes the baseline characteristics and treatment patterns of US patients hospitalized with a diagnosis of coronavirus disease 2019 (COVID‐19) and pulmonary involvement. Patients hospitalized with pulmonary involvement due to COVID‐
Autor:
Otis W. Brawley
Publikováno v:
Cancer. 127:1374-1376
Autor:
Ahmedin Jemal, Otis W. Brawley, Stacey A. Fedewa, Kevin J. Cullen, J. Leonard Lichtenfeld, Farhad Islami, Richard C. Wender, Jiemin Ma
Publikováno v:
CA: A Cancer Journal for Clinicians. 69:351-362
A summary evaluation of the 2015 American Cancer Society (ACS) challenge goal showed that overall US mortality from all cancers combined declined 26% over the period from 1990 to 2015. Recent research suggests that US cancer mortality can still be lo
Publikováno v:
Urologic Oncology: Seminars and Original Investigations. 40:195.e13-195.e18
The National Institutes of Health (NIH) Revitalization Act of 1993 established guidelines for the inclusion of racial/ethnic minorities and women in clinical research. However, the reporting rate of such patient demographic data in clinical trials fo
Publikováno v:
CA: A Cancer Journal for Clinicians. 69:50-79
From the mid-20th century, accumulating evidence has supported the introduction of screening for cancers of the cervix, breast, colon and rectum, prostate (via shared decisions), and lung. The opportunity to detect and treat precursor lesions and inv
Autor:
Kassandra I. Alcaraz, Corinne R. Leach, Rachel S. Cannady, Otis W. Brawley, Kim D. Miller, Tenbroeck Smith, Richard C. Wender, Catherine M. Alfano
Publikováno v:
CA: A Cancer Journal for Clinicians. 69:35-49
Cancer care delivery is being shaped by growing numbers of cancer survivors coupled with provider shortages, rising costs of primary treatment and follow-up care, significant survivorship health disparities, increased reliance on informal caregivers,
Autor:
Lauren R. Teras, Eric J. Jacobs, Otis W. Brawley, Jeffrey Drope, Clifford E Douglas, Alpa V. Patel, Richard C. Wender, Susan M. Gapstur, Marjorie L. McCullough
Publikováno v:
CA: A Cancer Journal for Clinicians. 68:446-470
In the United States, it is estimated that more than 1.7 million people will be diagnosed with cancer, and more than 600,000 will die of the disease in 2018. The financial costs associated with cancer risk factors and cancer care are enormous. To sub
Recent Patterns in Shared Decision Making for Prostate-Specific Antigen Testing in the United States
Autor:
Ann Goding Sauer, Stacey A. Fedewa, Ted Gansler, Robert A. Smith, Richard C. Wender, Ahmedin Jemal, Otis W. Brawley
Publikováno v:
The Annals of Family Medicine. 16:139-144
PURPOSE Previous studies report infrequent use of shared decision making for prostate-specific antigen (PSA) testing. It is unknown whether this pattern has changed recently considering increased emphasis on shared decision making in prostate cancer